Latest Breaking News On - Adriana williams - Page 5 : comparemela.com
Exyte Empowers the Biopharmaceutical Industry: First ExyCell® Facility Launched in Shanghai
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Exyte Delivers Excellent First Quarter 2021
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
FuerzaXMéxico firma acuerdo por todos lo que no tienen voz
24-horas.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 24-horas.mx Daily Mail and Mail on Sunday newspapers.
Exyte Delivers Record Sales in Challenging Macroeconomic Environment
News provided by
Share this article
Share this article
STUTTGART, Germany, May 12, 2021 /PRNewswire/ Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, delivered all-time high sales of €4.1 billion with adjusted EBIT of €213 million in the fiscal year 2020 (FY).
Exyte s €4.1 billion sales in 2020 exceeded 2019 s record-setting mark of €3.9 billion by 5%. Europe (EMEA) was the strongest region with sales climbing 75% year-over-year to €2.4 billion, much of which is attributable to semiconductor projects underway in Ireland and Austria and a data center project in Denmark. EMEA also won €2.2 billion worth of new orders. Although sales in Asia-Pacific (APAC) decreased slightly to €1.1 billion with the pandemic holding up some projects, its order intake was at the same amount, €1.1 billion. The situation was similar in the USA (AMER), with sales decreasing to
Exyte to build Dexcom s first manufacturing facility in Asia
STUTTGART, Germany and PENANG, Malaysia, April 15, 2021 /PRNewswire/ Exyte, world-renowned for the design and construction of high-tech facilities, has been awarded a fast-track project for Dexcom in Penang, Malaysia. This is the first manufacturing facility for the U.S.-based diabetes care technology provider outside the United States.
Exyte is proud to support Dexcom s strategic growth plans as it expands manufacturing into Asia for the first time. Located in Batu Kawan, Penang, and with 1.8 million square feet of gross floor area, the project will house a manufacturing facility for continuous glucose monitoring (CGM) systems. Key parts of the facility include multi-story cleanrooms, a warehouse with dock leveller, a three-story Central Utility Building (CUB), a seven-story office building with a canteen and recreational area as well as a seven-level multi-story parking structure.